Latigo Biotherapeutics, Inc. (LTGO)
12.50
-0.51
(-3.92%)
USD |
NASDAQ |
Nov 06, 09:59
Latigo Biotherapeutics Debt to Equity Ratio : 2.500 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.500 |
| Date | Value |
|---|---|
| March 31, 2026 | 0.0154 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Turn Therapeutics, Inc. | 8.911 |
| Journey Medical Corp. | 0.7953 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0108 |
| Veru, Inc. | 0.0945 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 64.76M |
| Total Liabilities (Quarterly) | 52.26M |
| Shareholders Equity (Quarterly) | 12.50M |
| Current Ratio | 1.148 |